Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Skin Neoplasms × Cryosurgery × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 22 Neoplasm Metastasis 18 Prostatic Neoplasms 11 Carcinoma, Renal Cell 9 Carcinoma, Hepatocellular 9 Sarcoma 8 Melanoma 8 Lung Neoplasms 8 Liver Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Kidney Neoplasms 7 Colorectal Neoplasms 6 Pain 5 Triple Negative Breast Neoplasms 3 Thyroid Neoplasms 3 Small Cell Lung Carcinoma 3 Osteosarcoma 3 Keratosis, Actinic 3 Esophageal Neoplasms 3 Desmoid Tumors 3 Colonic Neoplasms 3 Cholangiocarcinoma 3 Carcinoma, Ductal, Breast 3 Uterine Cervical Neoplasms 2 Tongue Neoplasms 2 Rectal Neoplasms 2 Ovarian Neoplasms 2 Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Intraductal, Noninfiltrating 2

Interventions

pembrolizumab 23 Nivolumab 20 aldesleukin 19 Cyclophosphamide 18 Ipilimumab 16 Interleukin-2 15 fludarabine 14 fludarabine phosphate 12 cemiplimab 11 Radiotherapy 7 Biopsy 7 dabrafenib 6 Surveys and Questionnaires 6 Fluorouracil 6 Dacarbazine 6 trametinib 5 binimetinib 5 Vemurafenib 5 Surgical Procedures, Operative 5 Radiation 5 Blood Specimen Collection 5 Aminolevulinic Acid 5 encorafenib 4 Temozolomide 4 Sirolimus 4 Photochemotherapy 4 Educational Status 4 sonidegib 3 montanide ISA 51 3 avelumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05779423 2026-01-06

Cryoablation+Ipilimumab+Nivolumab in Melanoma

Massachusetts General Hospital

Phase 2 Recruiting

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡